United States · FDA National Drug Code directory
ziprasidone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70518-4475_56197474-b3ec-ecc3-e063-6394a90a5846
- Product NDC
- 70518-4475
- Form
- CAPSULE
- Composition / generic term
- ziprasidone
- Labeler
- REMEDYREPACK INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250911
- Source listing expiry
- 20271231
Source-listed ingredients
- ZIPRASIDONE HYDROCHLORIDE — 60 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BLISTER PACK (70518-4475-0) · 70518-4475-0
- 30 POUCH in 1 BOX (70518-4475-1) / 1 CAPSULE in 1 POUCH (70518-4475-2) · 70518-4475-1
- 50 POUCH in 1 BOX (70518-4475-3) / 1 CAPSULE in 1 POUCH (70518-4475-2) · 70518-4475-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →